Raphael Pharmaceutical Inc. Investing Cash Flow
Raphael Pharmaceutical Inc. (RAPH) reported Investing Cash Flow of -$1.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2025-05-15
- Raphael Pharmaceutical Inc. net cash provided by (used in) investing activities for the quarter ending 2024-03-31 was -$1.00K.
- Raphael Pharmaceutical Inc. net cash provided by (used in) investing activities for the quarter ending 2022-12-31 was $0.00.
- Raphael Pharmaceutical Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$2.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|
| 2024-03-31 | -$1.00K 10-Q · filed 2025-05-15 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$2.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$2.00K 10-Q · filed 2023-11-14 |